GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2226 - 2250 of 4050 in total
Antibody Patient Onset (days) ▼ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 2 15 mild
G41200QS
1253
IgG Patient 2 15 mild
G42346AP
51
IgG Patient 2 15 mild
G42666HT
2761
IgG Patient 2 15 mild
G43534QA
30
IgG Patient 2 15 mild
G43648DB
85
IgG Patient 2 15 mild
G47362BJ
2542
IgG Patient 2 15 mild
G47548GA
80
IgG Patient 2 15 mild
G47566FL
4857
IgG Patient 2 15 mild
G48898TH
620
IgG Patient 2 15 mild
G49108TO
407
IgG Patient 2 15 mild
G49916XD
31
IgG Patient 2 15 mild
G51175PR
106
IgG Patient 2 15 mild
G51872EK
99
IgG Patient 2 15 mild
G52880ZN
32
IgG Patient 2 15 mild
G53168IY
58
IgG Patient 2 15 mild
G54064FW
98
IgG Patient 2 15 mild
G57449OF
209
IgG Patient 2 15 mild
G58547FH
41
IgG Patient 2 15 mild
G58969RU
45
IgG Patient 2 15 mild
G60761LT
845
IgG Patient 2 15 mild
G61399NC
105
IgG Patient 2 15 mild
G61751GZ
47
IgG Patient 2 15 mild
G62222PE
297
IgG Patient 2 15 mild
G62826CL
2402
IgG Patient 2 15 mild
G63074CQ
39

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024